Live Breaking News & Updates on Abcellera biologics

Stay informed with the latest breaking news from Abcellera biologics on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Abcellera biologics and stay connected to the pulse of your community

AbCellera Biologics (NASDAQ:ABCL) Stock Price Down 3.7%

AbCellera Biologics Inc. (NASDAQ:ABCL – Get Free Report) traded down 3.7% on Tuesday . The stock traded as low as $4.40 and last traded at $4.41. 577,359 shares changed hands during trading, a decline of 60% from the average session volume of 1,439,832 shares. The stock had previously closed at $4.58. Analyst Ratings Changes A […]

Eli-lilly , Stifel-nicolaus , Abcellera-biologics , Keycorp , Abcellera-biologics-inc , Nasdaq , Pathstone-family-office , Pricet-rowe-associates-inc , Pacifica-partners-inc , Abcellera-biologics-company-profile , Stansberry-asset-management , Belpointe-asset-management

Billionaire Investor Stan Druckenmiller and Insiders Are Piling Into These 11 Stocks

In this article, we will take a detailed look at Billionaire Investor Stan Druckenmiller and Insiders Are Piling Into These 11 Stocks. For a quick overview of such stocks, read our article Billionaire...

Canada , Poland , Las-vegas , Nevada , United-states , Canadian , Polen , Carl-icahn , Amy-banse , Sara-grootwassink-lewis , Warren-buffett , Jamesl-dolan

After losing 38% in the past year, AbCellera Biologics Inc. (NASDAQ:ABCL) institutional owners must be relieved by the recent gain

Key Insights Institutions' substantial holdings in AbCellera Biologics implies that they have significant influence...

Carl-hansen , Abcellera-biologics , Abcellera-biologics-inc , Baillie-gifford-co , Cellera-biologics , Baillie-gifford ,

AbCellera Biologics Inc. (NASDAQ:ABCL) Receives Average Rating of "Buy" from Brokerages

AbCellera Biologics Inc. (NASDAQ:ABCL – Get Free Report) has earned a consensus rating of “Buy” from the nine brokerages that are covering the firm, Marketbeat.com reports. Nine research analysts have rated the stock with a buy recommendation. The average 1-year price objective among brokers that have covered the stock in the last year is $15.86. […]

Montreal , Quebec , Canada , Stifel-nicolaus , Eli-lilly , Abcellera-biologics , Securities-inc , Abcellera-biologics-inc , Principal-financial-group-inc , Barclays-plc , Nasdaq , Raymond-james-associates

Analysts Set AbCellera Biologics Inc. (NASDAQ:ABCL) Target Price at $20.38

AbCellera Biologics Inc. (NASDAQ:ABCL – Get Free Report) has been assigned a consensus rating of “Buy” from the nine analysts that are covering the stock, MarketBeat reports. Nine research analysts have rated the stock with a buy recommendation. The average 12-month target price among brokerages that have updated their coverage on the stock in the […]

Montreal , Quebec , Canada , Stifel-nicolaus , Abcellera-biologics , Eli-lilly , Principal-financial-group-inc , Raymond-james-associates , Securities-inc , Barclays-plc , Nasdaq , Keycorp

AbCellera Announces Resignation of Board Member

AbCellera Announces Resignation of Board Member
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Vancouver , British-columbia , Canada , United-kingdom , British , Kathleen-reid , Peter-thiel , Murray-mccutcheon , Carl-hansen , Company-board-of-directors , Exchange-commission , Abcellera-biologics-inc

Obesity drugs to expand U.S. GDP by 1%: Goldman Sachs

Obesity drugs to expand U.S. GDP by 1%: Goldman Sachs
seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.

Jan-hatzius , Abcellera-biologics , Goldman-sachs , Images-group , Recursion-pharmaceuticals , Universal-images-group , Novo-nordisk , Eli-lilly , Structure-therapeutics ,

AbCellera Biologics Inc. (ABCL) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

Although the revenue and EPS for AbCellera Biologics Inc. (ABCL) give a sense of how its business performed in the quarter ended December 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Abcellera-biologics-inc , Zacks-investment-research , Key-company-metrics-for-abcellera-biologics-inc , Abcellera-biologics , Zacks-consensus-estimate , Wall-street , Key-company-metrics , Zacks-rank , Zacks-investment , Abcellera-biologics-inc- , Bcellera-biologics

AbCellera Biologics (ABCL) Q4 2023 Earnings Call Transcript

ABCL earnings call for the period ending December 31, 2023.

United-states , Canada , United-kingdom , America , British , Canadian , Robyn-karnauskas , Piper-sandler , Puneet-souda , Robyn-karnauskas-truist , Abcellera-biologics , Carl-hansen

AbCellera Biologics Inc. (NASDAQ:ABCL) Given Consensus Rating of "Moderate Buy" by Brokerages

AbCellera Biologics Inc. (NASDAQ:ABCL) Given Consensus Rating of "Moderate Buy" by Brokerages
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Canada , Abcellera-biologics , Eli-lilly , Keycorp , Abcellera-biologics-inc , Worth-asset-management , Nasdaq , Abcellera-biologics-company-profile , Pacifica-partners-inc , Securities-inc , National-bank , Get-free-report